{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T21:51:07Z","timestamp":1785880267669,"version":"3.56.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100015811","name":"Science and Technology Department of Ningxia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015811","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016692","name":"Key Research and Development Program of Ningxia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016692","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Signalling"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.cellsig.2026.112690","type":"journal-article","created":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T15:53:36Z","timestamp":1782143616000},"page":"112690","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["NUSAP1 mediates enzalutamide resistance in prostate cancer via Wnt\/\u03b2-catenin signalling\u2013dependent regulation of AR and AR-V7"],"prefix":"10.1016","volume":"146","author":[{"given":"Ning","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yajie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Congrong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaodong","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Libin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruining","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihong","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.cellsig.2026.112690_bb0005","first-page":"10","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.cellsig.2026.112690_bb0010","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.canlet.2018.11.008","article-title":"Targeting AR-Beclin 1 complex-modulated growth factor signaling increases the antiandrogen enzalutamide sensitivity to better suppress the castration-resistant prostate cancer growth","volume":"442","author":"Zhang","year":"2019","journal-title":"Cancer Lett."},{"issue":"10","key":"10.1016\/j.cellsig.2026.112690_bb0015","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.6004\/jnccn.2023.0050","article-title":"Prostate Cancer, version 4.2023, NCCN clinical practice guidelines in oncology","volume":"21","author":"Schaeffer","year":"2023","journal-title":"J. Natl. Compr. Canc. Netw."},{"issue":"22","key":"10.1016\/j.cellsig.2026.112690_bb0020","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14225719","article-title":"Current developments in cellular therapy for castration resistant prostate cancer: a systematic review of clinical studies","volume":"14","author":"Steinbach","year":"2022","journal-title":"Cancers"},{"issue":"9","key":"10.1016\/j.cellsig.2026.112690_bb0025","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a030452","article-title":"Androgen signaling in prostate cancer","volume":"7","author":"Dai","year":"2017","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"5","key":"10.1016\/j.cellsig.2026.112690_bb0030","doi-asserted-by":"crossref","first-page":"760","DOI":"10.17305\/bb.2023.8782","article-title":"Molecular basis and therapeutic targets in prostate cancer: a comprehensive review","volume":"23","author":"Militaru","year":"2023","journal-title":"Biomol Biomed."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112690_bb0035","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1186\/s13046-024-03125-5","article-title":"Emerging frontiers in androgen receptor research for prostate cancer: insights from the 2nd international androgen receptor symposium","volume":"43","author":"Israel","year":"2024","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.cellsig.2026.112690_bb0040","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1210\/endrev\/bnab002","article-title":"Hormonal therapy for prostate Cancer","volume":"42","author":"Desai","year":"2021","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.cellsig.2026.112690_bb0045","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.2147\/DDDT.S69433","article-title":"Enzalutamide for the treatment of metastatic castration-resistant prostate cancer","volume":"9","author":"Rodriguez-Vida","year":"2015","journal-title":"Drug Des. Devel. Ther."},{"issue":"9","key":"10.1016\/j.cellsig.2026.112690_bb0050","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1158\/2159-8290.CD-13-0142","article-title":"An F876L mutation in androgen receptor confers genetic and phenotypic resistance to MDV3100 (enzalutamide)","volume":"3","author":"Korpal","year":"2013","journal-title":"Cancer Discov."},{"issue":"3","key":"10.1016\/j.cellsig.2026.112690_bb0055","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.pharmthera.2013.07.003","article-title":"Androgen receptors in hormone-dependent and castration-resistant prostate cancer","volume":"140","author":"Shafi","year":"2013","journal-title":"Pharmacol. Ther."},{"issue":"19","key":"10.1016\/j.cellsig.2026.112690_bb0060","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14194877","article-title":"The crucial role of AR-V7 in enzalutamide-resistance of castration-resistant prostate cancer","volume":"14","author":"Zheng","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"13","key":"10.1016\/j.cellsig.2026.112690_bb0065","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202407715","article-title":"Tracing the evolution of sex hormones and receptor-mediated immune microenvironmental differences in prostate and bladder cancers: from embryonic development to disease","volume":"12","author":"Li","year":"2025","journal-title":"Adv Sci"},{"key":"10.1016\/j.cellsig.2026.112690_bb0070","first-page":"31","article-title":"Integrated multi-omics profiling of immune microenvironment and drug resistance signatures for precision prognosis in prostate cancer","volume":"8","author":"Li","year":"2025","journal-title":"Cancer Drug Resist."},{"issue":"6","key":"10.1016\/j.cellsig.2026.112690_bb0075","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1083\/jcb.200302129","article-title":"NuSAP, a novel microtubule-associated protein involved in mitotic spindle organization","volume":"162","author":"Raemaekers","year":"2003","journal-title":"J. Cell Biol."},{"issue":"6","key":"10.1016\/j.cellsig.2026.112690_bb0080","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1091\/mbc.e05-12-1178","article-title":"NuSAP, a mitotic RanGTP target that stabilizes and cross-links microtubules","volume":"17","author":"Ribbeck","year":"2006","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.cellsig.2026.112690_bb0085","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2025.1582361","article-title":"Research progress on NUSAP1 and its role in digestive system neoplasms","volume":"15","author":"Fu","year":"2025","journal-title":"Front. Oncol."},{"issue":"2","key":"10.1016\/j.cellsig.2026.112690_bb0090","doi-asserted-by":"crossref","DOI":"10.1083\/jcb.202108070","article-title":"NuSAP regulates microtubule flux and Kif2A localization to ensure accurate chromosome congression","volume":"223","author":"Sun","year":"2024","journal-title":"J. Cell Biol."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112690_bb0095","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/s12957-022-02652-9","article-title":"Evaluate the diagnostic and prognostic value of NUSAP1 in papillary thyroid carcinoma and identify the relationship with genes, proteins, and immune factors","volume":"20","author":"Gao","year":"2022","journal-title":"World J. Surg. Oncol."},{"issue":"7","key":"10.1016\/j.cellsig.2026.112690_bb0100","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24076258","article-title":"NUSAP1 binds ILF2 to modulate R-loop accumulation and DNA damage in prostate Cancer","volume":"24","author":"Chiu","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"18","key":"10.1016\/j.cellsig.2026.112690_bb0105","doi-asserted-by":"crossref","first-page":"29935","DOI":"10.18632\/oncotarget.15604","article-title":"NUSAP1 promotes invasion and metastasis of prostate cancer","volume":"8","author":"Gordon","year":"2017","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112690_bb0110","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/onc.2012.27","article-title":"Increased expression of NuSAP in recurrent prostate cancer is mediated by E2F1","volume":"32","author":"Gulzar","year":"2013","journal-title":"Oncogene"},{"issue":"12","key":"10.1016\/j.cellsig.2026.112690_bb0115","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1158\/0008-5472.CAN-17-3006","article-title":"Inhibition of the Wnt\/\u03b2-catenin pathway overcomes resistance to enzalutamide in castration-resistant prostate Cancer","volume":"78","author":"Zhang","year":"2018","journal-title":"Cancer Res."},{"issue":"45","key":"10.1016\/j.cellsig.2026.112690_bb0120","doi-asserted-by":"crossref","first-page":"6935","DOI":"10.1038\/s41388-020-01479-6","article-title":"Role of androgen receptor splice variant-7 (AR-V7) in prostate cancer resistance to 2nd-generation androgen receptor signaling inhibitors","volume":"39","author":"Zhu","year":"2020","journal-title":"Oncogene"},{"issue":"7","key":"10.1016\/j.cellsig.2026.112690_bb0125","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/j.1745-7270.2008.00440.x","article-title":"Wnt signaling: the good and the bad","volume":"40","author":"Chen","year":"2008","journal-title":"Acta Biochim. Biophys. Sin. Shanghai"},{"issue":"3","key":"10.1016\/j.cellsig.2026.112690_bb0130","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/gcc.10083","article-title":"Cadherin and catenin alterations in human cancer","volume":"34","author":"Hajra","year":"2002","journal-title":"Genes Chromosomes Cancer"},{"issue":"24","key":"10.1016\/j.cellsig.2026.112690_bb0135","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1001\/jama.2017.7248","article-title":"The diagnosis and treatment of prostate cancer: a review","volume":"317","author":"Litwin","year":"2017","journal-title":"JAMA"},{"issue":"37","key":"10.1016\/j.cellsig.2026.112690_bb0140","doi-asserted-by":"crossref","first-page":"59781","DOI":"10.18632\/oncotarget.10926","article-title":"Critical role of androgen receptor level in prostate cancer cell resistance to new generation antiandrogen enzalutamide","volume":"7","author":"Hoefer","year":"2016","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.cellsig.2026.112690_bb0145","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1158\/0008-5472.CAN-12-3630","article-title":"Androgen receptor splice variants mediate enzalutamide resistance in castration-resistant prostate cancer cell lines","volume":"73","author":"Li","year":"2013","journal-title":"Cancer Res."},{"issue":"10","key":"10.1016\/j.cellsig.2026.112690_bb0150","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqae114","article-title":"MED12 and CDK8\/19 modulate androgen receptor activity and enzalutamide response in prostate cancer","volume":"165","author":"Andolfi","year":"2024","journal-title":"Endocrinology"},{"issue":"5","key":"10.1016\/j.cellsig.2026.112690_bb0155","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/s41585-020-0298-8","article-title":"Cellular rewiring in lethal prostate cancer: the architect of drug resistance","volume":"17","author":"Carceles-Cordon","year":"2020","journal-title":"Nat. Rev. Urol."},{"issue":"3","key":"10.1016\/j.cellsig.2026.112690_bb0160","first-page":"294","article-title":"ANKRD22 enhances breast cancer cell malignancy by activating the Wnt\/\u03b2-catenin pathway via modulating NuSAP1 expression","volume":"21","author":"Wu","year":"2021","journal-title":"Bosn. J. Basic Med. Sci."},{"issue":"5","key":"10.1016\/j.cellsig.2026.112690_bb0165","article-title":"NUSAP1 recruits DAXX to suppress HIF-driven triple-negative breast cancer progression","volume":"13","author":"Du","year":"2026","journal-title":"Adv. Sci. (Weinh)"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112690_bb0170","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13046-019-1037-y","article-title":"Nucleolar and spindle associated protein 1 promotes metastasis of cervical carcinoma cells by activating Wnt\/\u03b2-catenin signaling","volume":"38","author":"Li","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"4","key":"10.1016\/j.cellsig.2026.112690_bb0175","doi-asserted-by":"crossref","first-page":"3886","DOI":"10.1002\/jcp.29282","article-title":"NUSAP1 knockdown inhibits cell growth and metastasis of non-small-cell lung cancer through regulating BTG2\/PI3K\/Akt signaling","volume":"235","author":"Xu","year":"2020","journal-title":"J. Cell. Physiol."},{"issue":"22","key":"10.1016\/j.cellsig.2026.112690_bb0180","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.21037\/atm-21-5517","article-title":"NUSAP1 promotes the metastasis of breast cancer cells via the AMPK\/PPAR\u03b3 signaling pathway","volume":"9","author":"Qiu","year":"2021","journal-title":"Ann Transl Med."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112690_bb0185","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.devcel.2009.06.016","article-title":"Wnt\/beta-catenin signaling: components, mechanisms, and diseases","volume":"17","author":"MacDonald","year":"2009","journal-title":"Dev. Cell"},{"issue":"5382","key":"10.1016\/j.cellsig.2026.112690_bb0190","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1126\/science.281.5382.1509","article-title":"Identification of c-MYC as a target of the APC pathway","volume":"281","author":"He","year":"1998","journal-title":"Science"},{"issue":"6726","key":"10.1016\/j.cellsig.2026.112690_bb0195","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1038\/18884","article-title":"Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells","volume":"398","author":"Tetsu","year":"1999","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.cellsig.2026.112690_bb0200","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1677\/erc.0.0100537","article-title":"Beta-catenin signaling in prostate cancer: an early perspective","volume":"10","author":"Chesire","year":"2003","journal-title":"Endocr. Relat. Cancer"},{"issue":"5","key":"10.1016\/j.cellsig.2026.112690_bb0205","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1128\/MCB.23.5.1674-1687.2003","article-title":"Beta-catenin binds to the activation function 2 region of the androgen receptor and modulates the effects of the N-terminal domain and TIF2 on ligand-dependent transcription","volume":"23","author":"Song","year":"2003","journal-title":"Mol. Cell. Biol."}],"container-title":["Cellular Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656826003451?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656826003451?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T21:33:27Z","timestamp":1785879207000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0898656826003451"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":41,"alternative-id":["S0898656826003451"],"URL":"https:\/\/doi.org\/10.1016\/j.cellsig.2026.112690","relation":{},"ISSN":["0898-6568"],"issn-type":[{"value":"0898-6568","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NUSAP1 mediates enzalutamide resistance in prostate cancer via Wnt\/\u03b2-catenin signalling\u2013dependent regulation of AR and AR-V7","name":"articletitle","label":"Article Title"},{"value":"Cellular Signalling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellsig.2026.112690","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"112690"}}